Aqueous dissolution of alzheimer's disease Aβ amyloid deposits by biometal depletion

被引:0
|
作者
Department of Pathology, University of Melbourne, Parkville, Vic. 3052, Australia [1 ]
不详 [2 ]
不详 [3 ]
不详 [4 ]
不详 [5 ]
不详 [6 ]
不详 [7 ]
机构
来源
J Biol Chem | / 33卷 / 23223-23228期
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Zn(II) and Cu(II) precipitate Aβ in vitro into insoluble aggregates that are dissolved by metal chelators. We now report evidence that these biometals also mediate the deposition of Aβ amyloid in Alzheimer's disease, since the solubilization of Aβ from post-mortem brain tissue was significantly increased by the presence of chelators, EGTA, N,N,N prime ,N prime -tetrakis(2-pyridyl-methyl) ethylene diamine, and bathocuproine. Efficient extraction of Aβ also required Mg(II) and Ca(II). The chelators were more effective in extracting Aβ from Alzheimer's disease brain tissue than age-matched controls, suggesting that metal ions differentiate the chemical architecture of amyloid in Alzheimer's disease. Agents that specifically chelate copper and zinc ions but preserve Mg(II) and Ca(II) may be of therapeutic value in Alzheimer's disease.
引用
收藏
相关论文
共 50 条
  • [31] RELATIONSHIP OF MICROGLIA AND ASTROCYTES TO AMYLOID DEPOSITS OF ALZHEIMER-DISEASE
    ITAGAKI, S
    MCGEER, PL
    AKIYAMA, H
    ZHU, S
    SELKOE, D
    JOURNAL OF NEUROIMMUNOLOGY, 1989, 24 (03) : 173 - 182
  • [32] Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease
    Urbanc, B
    Cruz, L
    Le, R
    Sanders, J
    Ashe, KH
    Duff, K
    Stanley, HE
    Irizarry, MC
    Hyman, BT
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (22) : 13990 - 13995
  • [33] Noradrenergic depletion potentiates β-amyloid-induced cortical inflammation:: implications for Alzheimer's disease
    Heneka, MT
    Galea, E
    Gavriluyk, V
    Dumitrescu-Ozimek, L
    Daeschner, J
    O'Banion, MK
    Weinberg, G
    Klockgether, T
    Feinstein, DL
    JOURNAL OF NEUROSCIENCE, 2002, 22 (07): : 2434 - 2442
  • [34] β-amyloid Peptides and Amyloid Plaques in Alzheimer's Disease
    Gouras, Gunnar K.
    Olsson, Tomas T.
    Hansson, Oskar
    NEUROTHERAPEUTICS, 2015, 12 (01) : 3 - 11
  • [35] β-amyloid Peptides and Amyloid Plaques in Alzheimer’s Disease
    Gunnar K. Gouras
    Tomas T. Olsson
    Oskar Hansson
    Neurotherapeutics, 2015, 12 : 3 - 11
  • [36] N-terminal heterogeneity of parenchymal and vascular amyloid-β deposits in Alzheimer's disease
    Zampar, S.
    Klafki, H. W.
    Sritharen, K.
    Bayer, T. A.
    Wiltfang, J.
    Rostagno, A.
    Ghiso, J.
    Miles, L. A.
    Wirths, O.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2020, 46 (07) : 673 - 685
  • [37] Amyloid-β deposits distinctively correlate with tangles and glial activation in Alzheimer's disease subtypes
    Boon, B. D. C.
    Kouri, N.
    Labuzan, S. A.
    Peng, Z.
    Tranovich, J. F.
    Frankenhauser, I.
    Lachner, C.
    Ertekin-Taner, N.
    Duara, R.
    Graff-Radford, N. R.
    Dickson, D.
    Murray, M. E.
    BRAIN PATHOLOGY, 2023, 33
  • [38] The galvanization of β-amyloid in Alzheimer's disease
    Bush, AI
    Tanzi, RE
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (11) : 7317 - 7319
  • [39] Amyloid, the presenilins and Alzheimer's disease
    Hardy, J
    TRENDS IN NEUROSCIENCES, 1997, 20 (04) : 154 - 159
  • [40] β-amyloid therapies in Alzheimer's disease
    Jhee, S
    Shiovitz, T
    Crawford, AW
    Cutler, NR
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (04) : 593 - 605